Search

everythinglearnresearchcommunity

for

Search:↓

PAS III can cause multiple autoimmune diseases with noticeable skin issues.

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Low-level laser therapy may help regrow hair in dogs with non-inflammatory hair loss.

iL-PRF treatment improves hair growth for androgenetic alopecia.

Low-level laser therapy, now called photobiomodulation, is recognized for its broad medical applications and scientific backing.

The conclusion is that using light-sheet fluorescence microscopy with a special solution can effectively create detailed 3D images of human skin for dermatological research.

Photobiomodulation can improve hair density and thickness, but it's costly and needs more research.

Low-Level Laser Therapy helps heal wounds and regenerate tissue when used correctly.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Polyunsaturated fatty acids, like arachidonic acid and eicosapentaenoic acid, can promote hair growth and may help treat hair loss.

PRP treatments and hair transplantation may be linked to the progression of pseudolymphoma to lymphoma.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

The improved nanoparticles can effectively target hair follicles for drug delivery.

A 59-year-old woman was diagnosed with a rare hair loss condition called lipedematous alopecia.

A 20-year-old had hair loss and skin issues from lichen planopilaris starting at age 10.

A woman's hair loss looked like a different condition due to her hairstyle, and treatment stopped further hair loss but didn't regrow hair.

Hair transplant destroyed by lichen planopilaris.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

Platelet-rich plasma injections can help treat hair loss in lupus patients.

Frontal Fibrosing Alopecia may be a complex condition linked to hormonal changes in women, not just a form of Lichen Planopilaris.

Hair transplants can work for frontal fibrosing alopecia and lichen planopilaris, but results are less favorable and the conditions can develop after the transplant.

Low level laser or LED therapy combined with infiltrations may help hair growth.

A new mutation in the LIPH gene was found to cause a rare hair disorder in a Japanese boy.